These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 428142)

  • 1. Inhibition of neutrophil chemotaxis in association with experimental angioedema in patients with cold urticaria: a model of chemotactic deactivation in vivo.
    Center DM; Soter NA; Wasserman SI; Austen KF
    Clin Exp Immunol; 1979 Jan; 35(1):112-8. PubMed ID: 428142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge.
    Wasserman SI; Soter NA; Center DM; Austen KF
    J Clin Invest; 1977 Jul; 60(1):189-96. PubMed ID: 874083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.
    Soter NA; Wasserman SI; Austen KF
    N Engl J Med; 1976 Mar; 294(13):687-90. PubMed ID: 55969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neutrophil chemotactic activity (NCA) during aspirin-induced urticaria and angioedema.
    Grzelewska-Rzymowska I
    Allergol Immunopathol (Madr); 1988; 16(4):231-6. PubMed ID: 3228043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Granulocytic "deactivation" in cold urticaria].
    Del Sere F; Gerini G; Velluzzi M; Petrini N; Fabbri P
    G Ital Dermatol Venereol; 1990 Oct; 125(10):423-8. PubMed ID: 2081620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Generation of eosinophil chemotactic factor of anaphylaxis in patients with cold urticaria and study of its in vitro chemotactic deactivation].
    Ibáñez MD; Leyva Cobián F; Díaz Gómez ML
    Med Clin (Barc); 1986 May; 86(19):794-7. PubMed ID: 3736185
    [No Abstract]   [Full Text] [Related]  

  • 7. Urticaria, angioedema, and mediator release in humans in response to physical environmental stimuli.
    Soter NA; Austen F
    Fed Proc; 1977 Apr; 36(5):1736-41. PubMed ID: 844616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional and physicochemical characterization of three eosinophilotactic activities released into the circulation by cold challenge of patients with cold urticaria.
    Wasserman SI; Austen KF; Soter NA
    Clin Exp Immunol; 1982 Mar; 47(3):570-8. PubMed ID: 7083632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediator release in local heat urticaria.
    Atkins PC; Zweiman B
    J Allergy Clin Immunol; 1981 Oct; 68(4):286-9. PubMed ID: 7288047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascaris and eosinophil. II. Isolation and characterization of eosinophil chemotactic factor and neutrophil chemotactic factor of parasite in Ascaris antigen.
    Tanaka J; Baba T; Torisu M
    J Immunol; 1979 Jan; 122(1):302-8. PubMed ID: 762419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High molecular weight neutrophil chemotactic factor: recognition, characterization, and role in the deactivation of neutrophillic leukocytes.
    Soter NA
    J Invest Dermatol; 1980 May; 74(5):354-6. PubMed ID: 7391608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
    Goetzl EJ; Tashjian AH; Rubin RH; Austen KF
    J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neutrophil chemotactic factor and its inhibitor found in DNCB-induced skin inflammatory lesions.
    Baba T; Tazaki K; Sonozaki H; Torisu M
    J Immunol; 1977 Mar; 118(3):762-8. PubMed ID: 845437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
    Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
    J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E, and defective neutrophil chemotaxis.
    Hill HR; Estensen RD; Hogan NA; Quie PG
    J Lab Clin Med; 1976 Nov; 88(5):796-806. PubMed ID: 978042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.